Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos One|August 12, 2016
Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- ActivityKatja Linher-Melville, Mina G Nashed, Robert G Ungard, et al.
Expert Opinion on Therapeutic Patents|September 24, 2015
A STAT inhibitor patent review: progress since 2011Ping-Shan Lai, David A Rosa, Ahmed Magdy Ali, et al.
Hepatology (Baltimore, Md.)|August 24, 2017
MicroRNA-337-3p controls hepatobiliary gene expression and transcriptional dynamics during hepatic cell differentiationCéline Demarez, Claude Gérard, Sabine Cordi, et al.
Chemmedchem|March 31, 2016
Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)-Resistant CML Lines While Circumventing Pharmacokinetic LiabilitiesAhmed M Ali, Rodolfo F Gómez-Biagi, David A Rosa, et al.
Molecular Cancer Therapeutics|February 14, 2016
Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer TherapeuticsCarolyn C Arpin, Stephen Mac, Yanlin Jiang, et al.
Oncotarget|August 29, 2015
STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activationMohini Singh, Neha Garg, Chitra Venugopal, et al.
Cancer Cell|January 16, 2019
The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor DiseaseLindsay Kosack, Bettina Wingelhofer, Alexandra Popa, et al.
Pageof 1